NEAT1 and metabolic dysfunction-associated steatotic liver disease: NEAT1 increases the development of hepatocellular carcinoma, NAFLD, and liver fibrosis while acting as a preventative in the pathogenesis of acute-on-chronic liver failure by suppressing the inflammatory response [130,131].